Ruby C.Y. Lin

6.5k total citations · 2 hit papers
79 papers, 4.8k citations indexed

About

Ruby C.Y. Lin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ruby C.Y. Lin has authored 79 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Epidemiology. Recurrent topics in Ruby C.Y. Lin's work include MicroRNA in disease regulation (16 papers), Bacteriophages and microbial interactions (12 papers) and Adipose Tissue and Metabolism (9 papers). Ruby C.Y. Lin is often cited by papers focused on MicroRNA in disease regulation (16 papers), Bacteriophages and microbial interactions (12 papers) and Adipose Tissue and Metabolism (9 papers). Ruby C.Y. Lin collaborates with scholars based in Australia, United States and Switzerland. Ruby C.Y. Lin's co-authors include Margaret J. Morris, Julie A. Owens, D. Ross Laybutt, Romain Barrès, Julie R. McMullen, Bianca C. Bernardo, Brian J. Morris, Ian W. Dawes, Jenny Y. Y. Ooi and Anthony S. McLean and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ruby C.Y. Lin

76 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring

2010 971 citations Ruby C.Y. Lin, Margaret J. Morris et al. profile →
Safety of bacteriophage therapy in severe Staphylococcus aureus infection

2020 331 citations Aleksandra Petrović Fabijan, Ruby C.Y. Lin et al. Nature Microbiology profile →

Peers

Countries citing papers authored by Ruby C.Y. Lin

Since Specialization

Citations

This map shows the geographic impact of Ruby C.Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby C.Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby C.Y. Lin more than expected).

Fields of papers citing papers by Ruby C.Y. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby C.Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby C.Y. Lin. The network helps show where Ruby C.Y. Lin may publish in the future.

Co-authorship network of co-authors of Ruby C.Y. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby C.Y. Lin. A scholar is included among the top collaborators of Ruby C.Y. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby C.Y. Lin. Ruby C.Y. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Policy in practice: Cystic Fibrosis Australia and Phage Australia surveys: understanding clinical needs and attitudes towards phage therapy in the cystic fibrosis community 2025 ·Stephanie Lynch, (unknown), Ameneh Khatami, (unknown), Jessica Sacher, (unknown), Ruby C.Y. Lin, Jonathan R. Iredell	0
2	Attitudes to phage therapy among Australian infectious diseases physicians 2025 ·International Journal of Antimicrobial Agents ·(unknown), Stephanie Lynch, Ameneh Khatami, (unknown), (unknown), Jessica Sacher, (unknown), Ruby C.Y. Lin, Jonathan R. Iredell	0
3	Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy 2023 ·Infection and Chemotherapy ·Shinwon Lee, Stephanie Lynch, Ruby C.Y. Lin, Heejoon Myung, Jonathan R. Iredell	4
4	Placental Histopathologic Findings of a Large Cohort of Patients With SARS-CoV-2 Infection During Pregnancy 2023 ·International Journal of Gynecological Pathology ·Ruby C.Y. Lin, (unknown), (unknown), (unknown), Rosanna Abellar, Monique M. Hedderson, Michael W. Kuzniewicz, Mara Greenberg	3
5	Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial 2022 ·BMJ Open ·Ameneh Khatami, David A. Foley, Morgyn S. Warner, Elizabeth H Barnes, Anton Y. Peleg, Jian Li, Stephen M. Stick, (unknown), Ruby C.Y. Lin, (unknown), Tom Snelling, Steven Y. C. Tong, Jonathan R. Iredell	41
6	Novel gene–intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy 2022 ·Brain ·(unknown), Ramesh K. Narayanan, (unknown), (unknown), Kaitao Lai, (unknown), Melina Ellis, Ruby C.Y. Lin, Brent Neumann, (unknown), Motonari Uesugi, Garth A. Nicholson, Steve Vucic, Mario Saporta, Marina Kennerson	9
7	Two plus One: Combination Therapy Tri-systems Involving Two Membrane-Disrupting Antimicrobial Macromolecules and Antibiotics 2022 ·ACS Infectious Diseases ·(unknown), (unknown), Ruby C.Y. Lin, Jiangtao Xu, Kang Liang, Edgar H. H. Wong	11
8	Accuracy of Magnetic Resonance Imaging for Identifying Ovarian Cancer in a Community-Based Setting 2022 ·Women s Health Reports ·Ruby C.Y. Lin, Yun‐Yi Hung, Julia N. Cheng, Elizabeth Suh‐Burgmann	1
9	Data to Power Precision Phage Therapy: A Look at the Phage Directory–Phage Australia Partnership 2022 ·PubMed Central ·Jessica Sacher, (unknown), Ruby C.Y. Lin	4
10	Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child 2021 ·EMBO Molecular Medicine ·Ameneh Khatami, Ruby C.Y. Lin, Aleksandra Petrović Fabijan, Sivan Alkalay‐Oren, (unknown), Philip N Britton, Michael Brownstein, (unknown), (unknown), Ronen Hazan, Bri’Anna Horne, Ran Nir‐Paz, Jonathan R. Iredell	51
11	Phage Biobank: Present Challenges and Future Perspectives 2021 ·Current Opinion in Biotechnology ·Ruby C.Y. Lin, Jessica Sacher, Pieter‐Jan Ceyssens, (unknown), Ali Khalid, Jonathan R. Iredell	30
12	Safety of bacteriophage therapy in severe Staphylococcus aureus infection breakdown → 2020 ·Nature Microbiology ·Aleksandra Petrović Fabijan, Ruby C.Y. Lin, Josephine Ho, Susan Maddocks, Nouri L. Ben Zakour, Jonathan R. Iredell, (unknown), Ali Khalid, Carola Venturini, Richard Chard, Sandra Morales, Indy Sandaradura, (unknown)	331
13	OA02.05 Expression of miR-223 in Mesothelioma Xenografts Originates from Stromal Cells in the Tumor Microenvironment 2017 ·Journal of Thoracic Oncology ·(unknown), Yuen Yee Cheng, Michaela B. Kirschner, Nico van Zandwijk, Ruby C.Y. Lin, Glen Reid	1
14	OA02.01 The microRNA-15/16 Family Regulates Tumor Cell Growth via Fibroblast Growth Factor Signals in Malignant Pleural Mesothelioma 2017 ·Journal of Thoracic Oncology ·Karin Schelch, Michaela B. Kirschner, Marissa Williams, Ruby C.Y. Lin, Yuen Yee Cheng, Michael Grusch, Walter Berger, Nico van Zandwijk, Glen Reid	2
15	Sex differences in response to miRNA‐34a therapy in mouse models of cardiac disease: identification of sex‐, disease‐ and treatment‐regulated miRNAs 2016 ·The Journal of Physiology ·Bianca C. Bernardo, Jenny Y. Y. Ooi, Aya Matsumoto, Yow Keat Tham, Saloni Singla, Helen Kiriazis, Natalie L. Patterson, Junichi Sadoshima, Susanna Obad, Ruby C.Y. Lin, Julie R. McMullen	38
16	Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload 2016 ·Scientific Reports ·Bianca C. Bernardo, (unknown), Xiao‐Ming Gao, Yow Keat Tham, Jenny Y. Y. Ooi, Natalie L. Patterson, Helen Kiriazis, Yidan Su, Colleen J. Thomas, Ruby C.Y. Lin, Xiao‐Jun Du, Julie R. McMullen	44
17	Gene expression in rat models for inter-generational transmission of islet dysfunction and obesity 2014 ·Genomics Data ·Ruby C.Y. Lin, (unknown), Margaret J. Morris	3
18	Human Induced Pluripotent Stem Cells Derived Under Feeder-Free Conditions Display Unique Cell Cycle and DNA Replication Gene Profiles 2011 ·Stem Cells and Development ·Henry Chung, Ruby C.Y. Lin, Grant J. Logan, Ian E. Alexander, Perminder S. Sachdev, Kuldip Sidhu	20
19	Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation 2009 ·American Journal Of Pathology ·Lynette Pretorius, Xiao‐Jun Du, Elizabeth A. Woodcock, Helen Kiriazis, Ruby C.Y. Lin, Silvana Marasco, Robert L. Medcalf, Ziqiu Ming, Geoffrey A. Head, Joon Win Tan, Nelly Cemerlang, Junichi Sadoshima, Tetsuo Shioi, Seigo Izumo, Е. В. Лукошкова, Anthony M. Dart, Garry Jennings, Julie R. McMullen	152
20	The Use of Gene-Expression Profiling to Identify Candidate Genes in Human Sepsis 2007 ·American Journal of Respiratory and Critical Care Medicine ·Benjamin Tang, Anthony S. McLean, Ian W. Dawes, Stephen Huang, Ruby C.Y. Lin	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact